The Recall Desk
SevereFDA (Devices)·Z-2557-2020·Announced 2020-07-22

CME America Recalls BodyGuard Microset Infusion Administration Sets

CME America is recalling BodyGuard Microset infusion administration sets due to delivery inaccuracy that could cause over- or under-infusion of therapy.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 per the rubric.

Plain-English summary

CME America, LLC is recalling BodyGuard Microset infusion administration sets (REF: A120-161XPS). The recall involves 345,244 units distributed across the United States and in Canada and the UK.

The recall was issued because the infusion administration sets may have a delivery inaccuracy ranging from minus 42.8% to plus 17.5%. This inaccuracy could cause over-infusion or under-infusion of therapy when used with an infusion pump system.

Healthcare facilities and consumers who have these products should stop using them and contact CME America for instructions on how to return or dispose of the devices.

The recalled product

Product
BodyGuard Microset, REF: A120-161XPS
Manufacturer
CME America, LLC
Affected units
345,244

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry date

Distribution

Part of a larger recall action

This product is one of 37 recalled by CME America, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 37 products in this recall →